Press release
Cancer Supportive Care Drugs Market to Exceed US$ 16.7 Billion by 2031: Transparency Market Research, Inc. Study
Cancer Supportive Care Drugs
The escalating global burden of cancer emerges as a pivotal driver propelling the expansion of the market for cancer supportive care drugs. As incidences of cancer rise, so does the demand for supportive care drugs.
Various therapeutic agents including G-CSFs, ESAs, antiemetics, bisphosphonates, opioids, NSAIDs, and topical treatments assume critical roles in addressing the multifaceted challenges associated with cancer care. The cancer supportive care drugs market caters to a wide array of cancer indications, encompassing lung, breast, prostate, liver, bladder, leukemia and melanoma.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ :
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85941&utm_source=OpenPR&utm_campaign=MansiR_OpenPR
The market's growth is further bolstered by diverse distribution channels such as hospital pharmacies, retail pharmacies, and compounding pharmacies. In meeting the evolving needs of cancer patients, the cancer supportive care drugs market fulfills a significant role, bridging crucial gaps in offering comprehensive and personalized cancer care solutions.
๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
Cancer supportive care drugs are medications tailored to alleviate the side effects and symptoms of cancer and its treatments, improving patients' quality of life during therapy. These drugs manage issues like pain, nausea, anemia, immune suppression, and bone complications. With the rise in cancer cases, addressing these challenges is vital.
Retail pharmacies are pivotal in distributing these drugs, providing accessibility and convenience that promote patient engagement and adherence to supportive care plans.
๐๐ฎ๐ซ๐ ๐ ๐ข๐ง ๐๐๐ง๐๐๐ซ ๐๐ง๐๐ข๐๐๐ง๐๐ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ ๐ซ๐๐ฌ๐ฌ
The surge in global cancer cases drives demand for supportive care drugs, essential for managing treatment side effects and enhancing patient well-being. With 1.9 million new cases and 608,570 deaths in the U.S. in 2021, and WHO attributing nearly 10 million deaths to cancer in 2020, the need for such drugs remains critical.
Healthcare acknowledges the pivotal role of supportive care drugs in mitigating treatment-related adverse effects amid rising cancer diagnoses. This recognition spurs pharmaceutical innovation to ensure patients receive comprehensive care for improved treatment outcomes.
Recent research, like the February 2021 study "Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention," underscores the growing evidence supporting NSAIDs' beneficial role in cancer care, inspiring ongoing exploration of innovative approaches.
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
Amgen, Inc., Merck & Co., Inc., Johnson & Johnson Services, Inc., Heron Therapeutics, Inc., Novartis AG, GSK plc, F. Hoffmann-La Roche Ltd., and Helsinn Healthcare SAย
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
Drug Class
G-CSFs (Granulocyte Colony-Stimulating Factor)
ESAs (Erythropoiesis Stimulating Agent)
Antiemetics
Bisphosphonates
Opioids
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)
Others (Topicals, etc.)
Indication
Lung Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Bladder Cancer
Leukemia
Others (Ovarian Cancer, Melanoma, etc.)
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others (Compounding Pharmacies, etc.)
๐๐๐ฒ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ
Inย March 2022, Imugene, an Australian biopharmaceutical company, announced a new clinical trial collaboration and supply agreement with MSD (Merck & Co., Inc.). The collaboration aims to evaluate the safety and efficacy of Imugene's HER-Vaxx, a B-cell activating immunotherapy, in combination with MSD's anti-PD-1 therapy, pembrolizumab (KEYTRUDA). The focus is on patients with HER-2 positive gastric cancer, presenting a promising approach to enhance treatment outcomes in this specific cancer subtype.
Inย March 2022, Novartis received approval from the U.S. Food and Drug Administration (FDA) for Pluvicto. The approval is for the treatment of adult patients with a specific type of advanced cancer known as prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC). Pluvicto is intended for patients who have already undergone other anticancer treatments, including androgen receptor pathway inhibition and taxane-based chemotherapy. This approval marks a significant development in providing advanced treatment options for this subset of prostate cancer patients.
๐๐ฅ๐๐๐ ๐๐ง ๐๐ซ๐๐๐ซ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=85941
๐๐๐จ๐ฎ๐ญ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
๐๐จ๐ง๐ญ๐๐๐ญ:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.comย ย ย ย ย
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Supportive Care Drugs Market to Exceed US$ 16.7 Billion by 2031: Transparency Market Research, Inc. Study here
News-ID: 3435434 • Views: โฆ
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 โฆ
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends fromโฆ
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra โฆ
The global Technetiumโ99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetiumโ99mโฆ
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to โฆ
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equineโฆ
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of โฆ
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,โฆ
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by โฆ
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emergingโฆ
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio โฆ
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boostโฆ
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne โฆ
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of theโฆ
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve โฆ
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:โฆ
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance โฆ
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launchโฆ
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung โฆ
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. Forโฆ
